...
首页> 外文期刊>Journal of Computer-Aided Molecular Design >Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening
【24h】

Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening

机译:人组胺H3 受体同源性模型的建立,用于配体对接和基于药效团的筛选

获取原文
获取原文并翻译 | 示例
           

摘要

The human histamine H3 receptor (hH3R) is a G-protein coupled receptor (GPCR), which modulates the release of various neurotransmitters in the central and peripheral nervous system and therefore is a potential target in the therapy of numerous diseases. Although ligands addressing this receptor are already known, the discovery of alternative lead structures represents an important goal in drug design. The goal of this work was to study the hH3R and its antagonists by means of molecular modelling tools. For this purpose, a strategy was pursued in which a homology model of the hH3R based on the crystal structure of bovine rhodopsin was generated and refined by molecular dynamics simulations in a dipalmitoylphosphatidylcholine (DPPC)/water membrane mimic before the resulting binding pocket was used for high-throughput docking using the program GOLD. Alternatively, a pharmacophore-based procedure was carried out where the alleged bioactive conformations of three different potent hH3R antagonists were used as templates for the generation of pharmacophore models. A pharmacophore-based screening was then carried out using the program Catalyst. Based upon a database of 418 validated hH3R antagonists both strategies could be validated in respect of their performance. Seven hits obtained during this screening procedure were commercially purchased, and experimentally tested in a [3H]Nα-methylhistamine binding assay. The compounds tested showed affinities at hH3R with K i values ranging from 0.079 to 6.3 μM.
机译:人类组胺H3 受体(hH3 R)是一种G蛋白偶联受体(GPCR),它调节中枢神经系统和周围神经系统中各种神经递质的释放,因此是该疾病的潜在靶点。治疗多种疾病。尽管解决该受体的配体是已知的,但是发现替代的前导结构代表了药物设计中的重要目标。这项工作的目的是通过分子建模工具研究hH3 R及其拮抗剂。为此目的,寻求一种策略,其中基于牛视紫红质的晶体结构产生hH3 的同源模型,并通过分子动力学模拟在二棕榈酰磷脂酰胆碱(DPPC)/水膜模拟物中生成,然后将其精制。使用程序GOLD将装订袋用于高通量对接。另外,还进行了基于药效基团的程序,其中使用了三种不同的有效hH3 R拮抗剂的所谓生物活性构象作为生成药效基团模型的模板。然后使用程序Catalyst进行基于药效团的筛选。根据418种经过验证的hH3 拮抗剂的数据库,可以对两种策略的性能进行验证。在此筛选过程中获得的七个命中物是商业购买的,并在[3 H]Nα-甲基组胺结合测定中进行了实验测试。测试的化合物在hH3 处显示亲和力,K i 值在0.079至6.3μM之间。

著录项

  • 来源
    《Journal of Computer-Aided Molecular Design》 |2007年第8期|437-453|共17页
  • 作者单位

    Institute of Pharmaceutical Chemistry Heinrich-Heine-Universität Düsseldorf Universitätsstr. 1 40197 Dusseldorf Germany;

    Institute of Pharmaceutical Chemistry Leopold-Franzens-Universität Innsbruck Innrain 52 Innsbruck 6020 Austria;

    Department of Pharmaceutical Chemistry Martin-Luther Universität Halle-Wittenberg Wolfgang-Langenbeckstr. 4 06120 Halle/Saale Germany;

    Institute of Pharmaceutical Chemistry Leopold-Franzens-Universität Innsbruck Innrain 52 Innsbruck 6020 Austria;

    Department of Pharmacology and Toxicology Institute of Pharmacy University of Regensburg 93040 Regensburg Germany;

    Department of Pharmacology and Toxicology Institute of Pharmacy University of Regensburg 93040 Regensburg Germany;

    Institute of Pharmaceutical Chemistry Biozentrum ZAFES/CMP Johann Wolfgang Goethe-Universität 60438 Frankfurt Germany;

    Institute of Pharmaceutical Chemistry Heinrich-Heine-Universität Düsseldorf Universitätsstr. 1 40197 Dusseldorf Germany;

    Department of Pharmaceutical Chemistry Martin-Luther Universität Halle-Wittenberg Wolfgang-Langenbeckstr. 4 06120 Halle/Saale Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Histamine; H3 receptor; Docking; Molecular dynamics; GOLD; Catalyst; Pharmacophore; Rhodopsin;

    机译:组胺;H3受体;对接;分子动力学;GOLD;催化剂;药基团;视紫红质;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号